Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K CURRENT REPORT   Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): May 5, 2026 BRISTOL-MYERS SQUIBB COMPANY (Exact Name of Registrant as Specified in its Charter) Delaware 001-01136 22-0790350 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) Route 206 & Province Line Road , Princeton , New Jersey 08543 (Address of Principal Executive Office) Registrant’s telephone number, including area code: ( 609 ) 252-4621 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))     Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.10 Par Value BMY New York Stock Exchange Celgene Contingent Value Rights CELG RT New York Stock Exchange 2.973% Notes due 2030 BMY/30 New York Stock Exchange 3.363% Notes due 2033 BMY/33 New York Stock Exchange 1.750% Notes due 2035 BMY35 New York Stock Exchange 3.857% Notes due 2038 BMY/38 New York Stock Exchange 4.289% Notes due 2045 BMY/45 New York Stock Exchange 4.581% Notes due 2055 BMY/55 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   Item 5.07 Submission of Matters to a Vote of Security Holders. (a) The Annual Meeting of the Company was held on May 5, 2026. (b) Shareholders voted on the matters set forth below.   Item 1. The shareholders elected each of the Company’s 11 nominees to serve as directors of the Company until the 2027 Annual Meeting based upon the following votes:     For Against Abstain Broker Non-Vote   Peter J. Arduini 1,489,115,718 46,952,408 2,517,271 234,927,659   Deepak L. Bhatt, M.D., M.P.H., M.B.A. 1,519,336,832 16,821,065 2,427,500 234,927,659   Christopher S. Boerner, Ph.D. 1,462,672,450 73,500,542 2,412,405 234,927,659   Julia A. Haller, M.D. 1,513,280,188 23,027,628 2,277,581 234,927,659   Manuel Hidalgo Medina, M.D., Ph.D. 1,513,107,431 23,055,022 2,422,944 234,927,659   Michael R. McMullen 1,520,590,126 15,506,431 2,488,840 234,927,659   Paula A. Price 1,506,560,939 29,652,099 2,372,359 234,927,659   Derica W. Rice 1,493,345,909 42,806,350 2,433,138 234,927,659   Theodore R. Samuels 1,487,884,432 48,111,146 2,589,819 234,927,659   Karen H. Vousden, Ph.D. 1,519,199,326 17,078,052 2,308,019 234,927,659   Phyllis R. Yale 1,527,736,604 8,485,885 2,362,908 234,927,659 Item 2.  The management proposal on the advisory vote to approve the compensation of our named executive officers was approved based upon the following votes: For Against Abstain Broker Non-Vote 1,459,162,310 72,490,026 6,933,061 234,927,659 Item 3. The management proposal on the vote to approve the Company’s 2026 stock award and incentive plan was approved based upon the following votes: For Against Abstain Broker Non-Vote 1,470,672,957 63,896,918 4,015,522 234,927,659 Item 4.   The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2026 was ratified based upon the following votes: For Against Abstain 1,706,279,839 63,727,901 3,505,316 Item 5.   The shareholder proposal on the adoption of a board policy that the chairperson of the board be an independent director was not approved based upon the following votes: For Against Abstain Broker Non-Vote 422,069,323 1,109,378,680 7,137,394 234,927,659 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.     BRISTOL-MYERS SQUIBB COMPANY     Dated: May 8, 2026 By: /s/ Amy Fallone   Name: Amy Fallone   Title: Corporate Secretary